Glaxo Smith Kline plc (GSK) launches a call for proposals for junior clinical researchers and Cameroon is one of the participating countries . Up to £100.000 over 2 years, will be available as funding, to support successful proposals from researchers in Côte d’Ivoire, Cameroon, Ghana, The Gambia, Nigeria, Kenya, Uganda and Malawi.
Glaxo Smith Kline plc (GSK) is one of the world’s leading research based pharmaceutical and healthcare companies . It is committed to improving the quality of human life by enabling people to do more, feel better and live longer.
In November 2014 the Open Lab launched its first call for proposals in eight African countries, with a total of £4 million made available to fund projects. In September 2015, a £5 million collaboration with the Medical Research Councils of the UK and South Africa was announced. This funding was used to launch a second call for proposals providing an opportunity to support researchers from South African institutions conducting research projects in NCDs.
This third call for proposals is targeted at outstanding African scientists in the early stages of their research and academic careers based in research institutions or universities in the following countries: Cameroon, Côte D’Ivoire, Ethiopia, Ghana, The Gambia, Kenya, Malawi, Nigeria, Uganda, Senegal and Tanzania.
Dr Agbor Ndip of the University of Manchester, with expertise in Diabetology / Clinical Research Director for GSK calls out junior Cameroonian and African researchers to submit their research proposals.
For more details, Click here